Evidence map›Paper›PMID 34806151›Full record

ReviewProbiotics and antimicrobial proteins2022

Precision Postbiotics and Mental Health: the Management of Post-COVID-19 Complications.

Muskan Pandey, Archana Bhati, Kumari Priya, K K Sharma, Barkha Singhal

Abstract readReview
In one paragraph

Review in Probiotics and antimicrobial proteins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muskan PandeySchool of Biotechnology, Gautam Buddha University, Greater Noida, Uttar Pradesh, 201312, India.
Archana BhatiSchool of Biotechnology, Gautam Buddha University, Greater Noida, Uttar Pradesh, 201312, India.
Kumari PriyaSchool of Biotechnology, Gautam Buddha University, Greater Noida, Uttar Pradesh, 201312, India.
K K SharmaDepartment of Microbiology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.ORCID https://orcid.org/0000-0001-9576-342X
Barkha SinghalSchool of Biotechnology, Gautam Buddha University, Greater Noida, Uttar Pradesh, 201312, India. barkha@gbu.ac.in.ORCID http://orcid.org/0000-0003-0538-662X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The health catastrophe originated by COVID-19 pandemic construed profound impact on a global scale. However, a plethora of research studies corroborated convincing evidence conferring severity of infection of SARS-CoV-2 with the aberrant gut microbiome that strongly speculated its importance for development of novel therapeutic modalities. The intense exploration of probiotics has been envisaged to promote the healthy growth of the host, and restore intestinal microecological balance through various metabolic and physiological processes. The demystifying effect of probiotics cannot be defied, but there exists a strong skepticism related to their safety and efficacy. Therefore, molecular signature of probiotics termed as "postbiotics" are of paramount importance and there is continuous surge of utilizing postbiotics for enhancing health benefits, but little is explicit about their antiviral effects. Therefore, it is worth considering their prospective role in post-COVID regime that pave the way for exploring the pastoral vistas of postbiotics. Based on previous research investigations, the present article advocates prospective role of postbiotics in alleviating the health burden of viral infections, especially SARS-CoV-2. The article also posits current challenges and proposes a futuristic model describing the concept of "precision postbiotics" for effective therapeutic and preventive interventions that can be used for management of this deadly disease.

Indexed as

COVID-19ProbioticsHumansMental HealthPandemicsPrebioticsProspective StudiesSARS-CoV-2PrebioticsDysbiosisGut-brain axisGut microbiomePostbioticsProbioticsSARS-CoV-2

Identifiers

PMID34806151
PMCPMC8606251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.